Teva Pharmaceutical Industries Ltd (TEVA) - Total Liabilities

Latest as of March 2026: ILA32.11 Billion ILA ≈ $86.10 Million USD

Based on the latest financial reports, Teva Pharmaceutical Industries Ltd (TEVA) has total liabilities worth ILA32.11 Billion ILA (≈ $86.10 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Teva Pharmaceutical Industries Ltd to track the company's year-over-year net asset growth rate.

Teva Pharmaceutical Industries Ltd - Total Liabilities Trend (1985–2025)

This chart illustrates how Teva Pharmaceutical Industries Ltd's total liabilities have evolved over time, based on quarterly financial data. See TEVA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Teva Pharmaceutical Industries Ltd Competitors by Total Liabilities

The table below lists competitors of Teva Pharmaceutical Industries Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Capital Clean Energy Carriers Corp. NASDAQ:CCEC	USA	$2.60 Billion
Adriatic Metals Plc F:3FN	Germany	€192.27 Million
Kestra Medical Technologies, Ltd. Common Stock NASDAQ:KMTS	USA	$91.35 Million
Jiangling Motors Corp Ltd SHE:000550	China	CN¥17.79 Billion
Nabors Industries Ltd F:NBI1	Germany	€2.94 Billion
Zensar Technologies Limited NSE:ZENSARTECH	India	Rs11.33 Billion
Heidrick & Struggles International NASDAQ:HSII	USA	$755.04 Million
Guangdong Macro Co Ltd SHE:000533	China	CN¥1.76 Billion

Liability Composition Analysis (1985–2025)

This chart breaks down Teva Pharmaceutical Industries Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TEVA company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Teva Pharmaceutical Industries Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Teva Pharmaceutical Industries Ltd (1985–2025)

The table below shows the annual total liabilities of Teva Pharmaceutical Industries Ltd from 1985 to 2025.

Year	Total Liabilities	Change
2025-12-31	ILA32.84 Billion ≈ $88.05 Million	-2.28%
2024-12-31	ILA33.61 Billion ≈ $90.10 Million	-4.94%
2023-12-31	ILA35.35 Billion ≈ $94.78 Million	+0.11%
2022-12-31	ILA35.31 Billion ≈ $94.68 Million	-3.04%
2021-12-31	ILA36.42 Billion ≈ $97.65 Million	-7.98%
2020-12-31	ILA39.58 Billion ≈ $106.11 Million	-6.67%
2019-12-31	ILA42.41 Billion ≈ $113.69 Million	-5.53%
2018-12-31	ILA44.89 Billion ≈ $120.35 Million	-13.46%
2017-12-31	ILA51.87 Billion ≈ $139.06 Million	-10.41%
2016-12-31	ILA57.90 Billion ≈ $155.22 Million	+137.96%
2015-12-31	ILA24.33 Billion ≈ $65.23 Million	+5.49%
2014-12-31	ILA23.07 Billion ≈ $61.84 Million	-7.27%
2013-12-31	ILA24.87 Billion ≈ $66.68 Million	-10.35%
2012-12-31	ILA27.74 Billion ≈ $74.38 Million	-0.21%
2011-12-31	ILA27.80 Billion ≈ $74.53 Million	+63.04%
2010-12-31	ILA17.05 Billion ≈ $45.71 Million	+17.17%
2009-12-31	ILA14.55 Billion ≈ $39.01 Million	-12.05%
2008-12-31	ILA16.54 Billion ≈ $44.35 Million	+71.40%
2007-12-31	ILA9.65 Billion ≈ $25.88 Million	+3.85%
2006-12-31	ILA9.29 Billion ≈ $24.92 Million	+114.29%
2005-12-31	ILA4.34 Billion ≈ $11.63 Million	+2.48%
2004-12-31	ILA4.23 Billion ≈ $11.35 Million	+61.55%
2003-12-31	ILA2.62 Billion ≈ $7.02 Million	-6.18%
2002-12-31	ILA2.79 Billion ≈ $7.49 Million	+34.43%
2001-12-31	ILA2.08 Billion ≈ $5.57 Million	+22.01%
2000-12-31	ILA1.70 Billion ≈ $4.56 Million	+75.22%
1999-12-31	ILA971.72 Million ≈ $2.61 Million	+25.16%
1998-12-31	ILA776.40 Million ≈ $2.08 Million	+34.89%
1997-12-31	ILA575.60 Million ≈ $1.54 Million	-18.49%
1996-12-31	ILA706.20 Million ≈ $1.89 Million	+52.30%
1995-12-31	ILA463.70 Million ≈ $1.24 Million	+39.00%
1994-12-31	ILA333.60 Million ≈ $894.37K	+13.08%
1993-12-31	ILA295.00 Million ≈ $790.88K	+32.94%
1992-12-31	ILA221.90 Million ≈ $594.91K	+14.56%
1991-12-31	ILA193.70 Million ≈ $519.30K	-6.96%
1990-12-31	ILA208.20 Million ≈ $558.18K	+24.45%
1989-12-31	ILA167.30 Million ≈ $448.53K	+12.28%
1988-12-31	ILA149.00 Million ≈ $399.46K	+75.29%
1986-12-31	ILA85.00 Million ≈ $227.88K	-4.71%
1985-12-31	ILA89.20 Million ≈ $239.14K	--

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$32.44 Billion

ILA12.10 Trillion ILA

Market Cap Rank

#8049 Global

#69 in Israel

Share Price

ILA10390.00

Change (1 day)

-0.38%

52-Week Range

ILA5600.00 - ILA11350.00

All Time High

ILA25447.60